** Shares of life science firm Avantor AVTR.N down 16.1% at $13 in early trading
** Stock trading at its lowest since April 2020
** Co announces Michael Stubblefield to step down as CEO as soon as successor is found
** Posts Q1 net sales of $1.58 bln, slightly below estimate of $1.60 bln - data compiled by LSEG
** AVTR reports adj. EPS of 23 cents, matching analysts' expectations
** Fourteen of 24 brokerages rate the stock "buy" or higher, 10 "hold"; median PT is $21.50 - data compiled by LSEG
** Including day's move, AVTR down 26.4% YTD
(Reporting by Twesha Dikshit)
((Twesha.Dikshit@thomsonreuters.com))
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。